Sorafenib (Nexavar) 200mg*60's | Bayer China-Sourced Originator | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

Share
Product description

Generic Information: Nexavar (China-Mainland)

This is Bayer's originator sorafenib, marketed in mainland China as Nexavar (多吉美). Each tablet contains 200 mg of sorafenib tosylate, and the box holds 60 tablets. The product is approved by China's National Medical Products Administration (NMPA) and has been included in the national medical-insurance catalogue, which means eligible patients in China can obtain it with significant reimbursement for its three approved indications.

What Is Sorafenib Used For?

In China, sorafenib is approved for unresectable hepatocellular carcinoma, advanced renal cell carcinoma, and differentiated thyroid carcinoma that is refractory to radioactive iodine. It is a first-line oral targeted therapy for advanced liver cancer and remains a standard option for patients who cannot undergo surgery or whose cancer has spread.

How Does Sorafenib Work?

Sorafenib is a multikinase inhibitor targeting CRAF/BRAF and the receptor tyrosine kinases VEGFR-2/3, PDGFR-beta, c-Kit and FLT3. This dual action blocks cancer-cell proliferation and angiogenesis, starving tumours of blood supply and slowing disease progression.

Indications

The three approved indications in China mirror the global label: unresectable HCC, advanced RCC, and radioiodine-refractory DTC. Patients must have a confirmed diagnosis and a prescription from an oncology specialist to access the reimbursed supply.

Dosage

The recommended dose is 400 mg twice daily (800 mg total per day), taken on an empty stomach, at least one hour before or two hours after meals. Doses are adjusted downward in a stepwise manner when side effects appear. Because each box has 60 tablets of 200 mg, one box covers roughly 15 days of standard dosing.

Side Effects

Frequent adverse reactions are hand-foot skin reaction, diarrhoea, fatigue, rash, hypertension, nausea and hair thinning. Rare but serious effects include liver injury, bleeding, cardiac events and gastrointestinal perforation. Regular monitoring of blood pressure, liver function and blood counts is required throughout treatment.

Storage

Store at room temperature in a dry place, keep the tablets in the original blister pack, and do not use after the expiry date.

Why Choose the China Version of Nexavar?

The China version of Nexavar is priced substantially lower than the same originator product in Western markets. In China, sorafenib is reimbursable through the national medical-insurance programme for eligible patients, and the China list price is roughly a fraction of the United States retail price and several times cheaper than in many European countries. For overseas patients and institutions sourcing through GLT, this translates into meaningful savings on genuine Bayer sorafenib.

How to Order

Reach our team on WhatsApp at +86 15234153837 or email [email protected] to order China-sourced Nexavar. We will confirm current availability, price and shipping arrangements from our Hong Kong-licensed facility before you place an order.

FAQ

Is Nexavar reimbursed in China? Yes, the originator sorafenib has been included in China's national medical-insurance catalogue, so eligible patients with the approved indications can receive reimbursement.

Is the China version the same as the German version? Yes, it is the same Bayer originator formulation approved by the NMPA for the Chinese market.

How do I buy it from outside China? Contact GLT directly; we handle international sourcing and shipping of China-version Nexavar for qualified buyers.

Related Oncology Products

Orforglipron (LuciOrfor) 0.8–17.2mg Tablets | Laos Generic Oral GLP-1 | GLT

Lucius Pharmaceuticals (Laos) generic orforglipron, 6-dose titration for weight management

Mounjaro KwikPen (Tirzepatide) 10–60mg/2.4mL Multi-Dose | Eli Lilly USA | GLT

Mounjaro KwikPen — Eli Lilly single-patient multi-dose pen, six US strengths (10–60mg/2.4mL, 4 doses each)...

Zepbound (Tirzepatide) 2.5–15mg/0.5mL Single-Dose Pen | Eli Lilly USA | GLT

Zepbound — Eli Lilly tirzepatide single-dose pen, six US strengths (2.5–15mg/0.5mL) for chronic weight management...

Tirzema (Tirzepatide) 2.5/5/7.5mg/0.5mL Single-Dose Pen | Incepta Bangladesh | GLT

Tirzema — Incepta Pharmaceuticals tirzepatide single-dose pen, three official strengths (2.5/5/7.5mg/0.5mL) for T2DM and weight...

Olumiant (Baricitinib) 2mg/4mg Tablets | JAK1/JAK2 Inhibitor | Eli Lilly USA | GLT

Eli Lilly's selective JAK1/JAK2 inhibitor for rheumatoid arthritis, atopic dermatitis and severe alopecia areata.

Tixepa (Tirzepatide) 20mg/2mL & 30mg/2mL Multi-Dose Pen | Drug International | GLT

Tixepa — Drug International Limited (DIL) tirzepatide multi-dose pen, two official strengths (Tixepa-5 = 20mg/2mL,...

LuciAvat (Avatrombopag) 20mg*28 Tablets | Lucius Pharmaceuticals Laos | GLT

LuciAvat — avatrombopag 20mg (23.6mg maleate) film-coated tablets by Lucius Pharmaceuticals (Lao) Co., Ltd., Vientiane

Palutini (Baricitinib) 4mg | Generic JAK1/JAK2 Inhibitor | Trans Continental Life Science & Pharmaceuticals (TLPH) | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Trans Continental Life Science & Pharmaceuticals (TLPH) (Laos) — an...